介质非常低密度脂蛋白胆固醇与总脂质的比率和胃潰瘍之间的因果关系:双向孟德尔随机化研究
Chun-Mei Lin1, Qian Meng1, Ying-Jun Li1
1Postgraduate Student, Guangzhou University of Chinese Medicine, Guangzhou 510006, Guangdong Province, China.
World journal of clinical cases
|September 9, 2024
概括
非常低密度脂蛋白 (VLDL) 中的胆固醇与总脂质的比率与胃风险增加有关. 需要进一步的研究来证实这种关联及其因果关系.
科学领域:
- 心血管遗传学 心血管遗传学
- 胃肠病学 胃肠病学
- 流行病学 流行病学
背景情况:
- 流行病学研究表明,VLDL胆固醇-脂质比率和胃潰瘍 (PU) 之间存在联系.
- 在VLDL胆固醇脂比和PU之间的确切因果关系仍然不清楚.
- 这项研究使用遗传方法调查了这种关联.
研究的目的:
- 探索胆固醇与总脂质的比例在中等非常低密度脂蛋白 (VLDL) 和胃潰瘍 (PU) 发病率中的关联.
- 利用遗传方法,特别是孟德尔随机化 (MR),来研究这种关系.
- 为未来的PU病因学临床研究提供指导.
主要方法:
- 对于VLDL胆固醇-脂质比率和PU的全基因组关联研究 (GWAS) 数据来自IEU OpenGWAS项目.
- 前期MR分析使用72个与VLDL比率相关的SNP作为PU的仪器变量.
- 反向MR分析是不可行的,因为缺乏适合的SNPPU作为暴露.
主要成果:
- 前期的MR分析表明,基因预测的VLDL胆固醇-脂质比率与增加的胃风险之间存在显著的关联 (OR = 2.557,P = 0.008).
- 反向MR分析没有发现胃潰瘍与VLDL胆固醇-脂质比率的因果关系.
- 使用MR-Egger,加权中位数和留出一个方法来评估性和异质性.
结论:
- 在VLDL胆固醇-脂质比率和胃风险增加之间存在显著的关联.
- 这种关联的因果性需要进一步调查.
- 建议进行实验室研究和更大的队列来验证.
相关概念视频
01:30Peptic Ulcer Disease I: Introduction
144
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
144
01:24Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
358
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
358
01:22Pathophysiology of Peptic Ulcer Disease: Injurious Factors
545
Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
545
01:28Peptic Ulcer Disease II: Pathophysiology
322
Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
322
01:26Peptic Ulcer Disease IV: Management
75
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
75
01:28Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
97
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
97